We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
“True, I believe avct are 6 weeks till validation min. The difference is that avct are massively ramping up their production capability for a global demand, if only odx had this vision“
ODX are in the process of ramping up production from around 375,000(if I remember rightly) to 2,000,000 tests per week. Whilst achieving sales approval in India.
So ODX have done pretty much exactly the same ramping up production capability for global demand. However we are in essence 2 months ahead? Whilst AVCT still maintain the risk of passing such stages.
Makes ODX sound even better when they’re miles ahead of similarly placed companies!
I think it’s safe to say that all our planned manufacturing capacity must be taken up with our own products.
True, I believe avct are 6 weeks till validation min. The difference is that avct are massively ramping up their production capability for a global demand, if only odx had this vision
https://twitter.com/_Erin_Kate/status/1291254713422315521/photo/1
some more press coverage
ODX are miles ahead of AVCT, with production only months away.
9th June trading update, deal signed with mologic
New MTA covering additional Mologic COVID-19 tests
In addition, Omega announces it has widened its collaboration with Mologic by signing another Material Transfer Agreement ("MTA"), providing the Company with access to raw materials and know-how to manufacture the following additional Mologic COVID-19 tests:
· an ELISA antigen test that determines the concentration of COVID-19 (SARS-CoV-2) antigens in human blood, saliva or swab extract sample thereby identifying an individual with an active COVID-19 infection
· a lateral flow antigen test product that determines the concentration of COVID-19 (SARS-CoV-2) antigens in a human blood, saliva, or swab extract sample also used to identify an individual with an infection
· a lateral flow antibody test product that determines the concentration of human antibodies in a human blood sample specifically targeting the COVID-19 (SARS-CoV-2) antigens
Omega intends to CE-Mark the above additional tests under the MTA, after which both parties will work together to commercialise the tests under an expanded Supply Agreement arrangement. The MTA will enable Omega to broaden its growing portfolio of COVID-19 tests, using both its Scottish and English manufacturing sites more effectively, and will ensure it can meet the different needs of global healthcare systems that require both antibody tests (denoting previous infection) and antigen tests (denoting current infection) in a range of formats.
"BBI are out of manufacturing the RTC test"
Says who?
BBI are out of manufacturing the RTC test
thats great news for us
this is IMO
Is there definitely a clause that states we can't work with other manufacturers? I can see why that's unlikely, but I haven't read anything that states we can only work with Mologic?
Their making a saliva based antigen test the same as what odx are working on with mologic. I doubt we shall work directly with them as we will have our own.
What this shows is the poc saliva test is the way to go and we are as close, uptodate as anyone in this field, we await the mologic update.
Just appointed BBI solutions as their manufacturing partner. Wondered if any of that manufacturing might overflow to ODX? Question to anyone more knowledgeable than me, thanks. I still haven't totally got my head around the relationship with BBI here.